Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.2K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

300
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
300
Binge Eating Disorders01:23

Binge Eating Disorders

212
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
212
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

448
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
448
Anorexia Nervosa01:28

Anorexia Nervosa

270
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between Grandparental Involvement and Children's Diet-Related Behaviors and Weight Status: A Systematic Review.

Nutrition reviews·2026
Same author

Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes.

Diabetes·2026
Same author

Supporting Infants With Severe Combined Immunodeficiency and Their Mothers During Breastfeeding Cessation Due to Cytomegalovirus Risk.

The journal of allergy and clinical immunology. In practice·2026
Same author

Eating Disorders Prevention and Management Among Australian and New Zealand Dietetic Professionals: A Repeat Cross-Sectional Study Exploring Training Needs and Future Opportunities.

The International journal of eating disorders·2026
Same author

Dietary assessment methodologies in eating disorders: a pilot comparative validation study exploring the diet history method.

Journal of eating disorders·2025
Same author

Macronutrient Intake in Children and Adolescents with Type 1 Diabetes and Its Association with Glycemic Outcomes.

Pediatric diabetes·2025

Related Experiment Video

Updated: Oct 11, 2025

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

4.0K

Screening Practices for Disordered Eating in Paediatric Type 1 Diabetes Clinics.

Emma Hanley Burden1, Melissa Hart1,2, Kirrilly Pursey1

  • 1College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia.

Nutrients
|November 27, 2021
PubMed
Summary

Most Australasian pediatric Type 1 Diabetes (T1D) clinics do not use screening tools for disordered eating. This may lead to undetected eating disorders, missing crucial early intervention opportunities in youth with T1D.

Keywords:
Pediatricsadolescentsearly interventionfeeding and eating disordersscreeningtype 1 diabetes mellitus

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.2K

Related Experiment Videos

Last Updated: Oct 11, 2025

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

4.0K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.2K

Area of Science:

  • Endocrinology
  • Pediatric Health
  • Mental Health

Background:

  • Type 1 Diabetes (T1D) is linked to a higher risk of eating disorders in children and adolescents.
  • Effective screening for disordered eating is crucial for early intervention in this vulnerable population.

Purpose of the Study:

  • To evaluate how well Australasian pediatric T1D clinics follow international guidelines for screening disordered eating.
  • To identify challenges and facilitators influencing the use of screening tools for disordered eating in these clinics.

Main Methods:

  • A 24-item survey was distributed to Australasian clinics managing at least 150 pediatric patients with T1D.
  • The survey assessed clinic characteristics, disordered eating identification practices, screening tool usage, staff training, and referral pathways.

Main Results:

  • Ten out of 13 eligible clinics participated. Most reported low rates of disordered eating (<5%).
  • All clinics primarily used clinical interviews; only one utilized screening tools, which were not diabetes-specific or routinely employed.
  • Key barriers to tool use included time constraints and staff confidence issues (70%), while staff training was an identified enabler.

Conclusions:

  • Screening tools for disordered eating are underutilized in most Australasian pediatric T1D clinics.
  • The low reported prevalence of disordered eating may indicate underdetection, potentially hindering timely intervention.